Figure 4.
AMD3100 enhances tumor reduction induced by bortezomib in vivo. (B) Representative bioluminescence images of each treatment group with time.
AMD3100 enhances tumor reduction induced by bortezomib in vivo. (B) Representative bioluminescence images of each treatment group with time.
